EU Paediatric Regulation “not tackling off-label use of existing drugs”
This article was originally published in SRA
Executive Summary
The EU Paediatric Regulation has not helped reduce the off-label use of medicines in children, the European Medicines Agency's Network of Paediatric Research (Enpr-EMA) has stated in a report outlining its experience with the legislation1.